MP28445 – pFUSE2ss-aRD114_CLIg-mIgK
(Plasmid
#110556)
-
PurposepFUSE backbone with an IL2 signal sequence, expressing the variable light chain of anti-RD114 binder fused to murine Kappa constant light chain.
-
Depositing Lab
-
Sequence Information
-
Sequences (1) — Accept Affinity Reagent Sequence Policy
-
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 110556 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepFUSEss
-
Backbone manufacturerInvivogen
- Backbone size w/o insert (bp) 3456
- Total vector size (bp) 4162
-
Vector typeMammalian Expression, Bacterial Expression
-
Selectable markersBlasticidin
Growth in Bacteria
-
Bacterial Resistance(s)Blasticidin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameanit-RD114 light chain
-
Alt nameaRD114_CLIg-mIgK
-
SpeciesRD114 retrovirus
-
GenBank IDNCBI:txid11834
- Promoter EF-1 alpha core promoter
-
Tag
/ Fusion Protein
- mKappa (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site EcoRI (not destroyed)
- 3′ cloning site NheI (not destroyed)
- 5′ sequencing primer n/a
- 3′ sequencing primer n/a (Common Sequencing Primers)
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
MP28445 – pFUSE2ss-aRD114_CLIg-mIgK was a gift from Martin Pule (Addgene plasmid # 110556 ; http://n2t.net/addgene:110556 ; RRID:Addgene_110556) -
For your References section:
Generation of a neutralizing antibody against RD114-pseudotyped viral vectors. Mekkaoui L, Ferrari M, Mattiuzzo G, Ma B, Nannini F, Onuoha S, Kotsopoulou E, Takeuchi Y, Pule M. J Gen Virol. 2019 Nov 8. doi: 10.1099/jgv.0.001309. 10.1099/jgv.0.001309 PubMed 31702531